Concepedia

Author

G. Carretero

Hospital Universitario de Gran Canaria Doctor NegrínORCID

Also Known As

D. Vidal, G Carretero, G Moreno Carretero, G. Carretero, Graciela Pellerano, Gregorio Carretero, J.M. Carrascosa, Mariano Ara

137

Publications

2.8K

Citations

30

H-Index

81

Concepts

All Affiliations

Hospital Universitario de Gran Canaria Doctor NegrínHospital Universitario de La PrincesaHospital Universitari Germans Trias i PujolHospital Universitario Fundación AlcorcónHospital General Universitario de Alicante Doctor Balmis
GC

About

G. Carretero is an author at Hospital Universitario de Gran Canaria Doctor Negrín specializing in medicine, dermatology, and psoriatic arthritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

20

743

2

Engineering

4

4

162

3

Public Health

2

2

40

4

Social Sciences

1

1

30

5

Biostatistics

1

1

108

G. Carretero

×

39

Publications

1.6K

Citations

23

H-Index

YearCitations

Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases

A. Català, C. Muñoz‐Santos, Cristina Galván‐Casas,

British Journal of Dermatology

2021

240

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry

P. Dávila‐Seijo, E. Daudén, M.Á. Descalzo,

Journal of Investigative Dermatology

2016

123

Non-Invasive Skin Cancer Diagnosis Using Hyperspectral Imaging for In-Situ Clinical Support

Raquel León, Beatriz Martinez-Vega, Himar Fabelo,

Journal of Clinical Medicine

2020

108

Survival of classic and biological systemic drugs in psoriasis: results of the <scp>BIOBADADERM</scp> registry and critical analysis

P. Dávila‐Seijo, E. Daudén, G. Carretero,

Journal of the European Academy of Dermatology and Venereology

2016

97

Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry

J.M. Carrascosa, M. Vilavella, I. García‐Doval,

Journal of the European Academy of Dermatology and Venereology

2013

75

Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry

G. Carretero, E. Daudén, Francisco Vanaclocha Sebastián,

Journal of the European Academy of Dermatology and Venereology

2014

65

Spanish Evidence-Based Guidelines on the Treatment of Psoriasis With Biologic Agents, 2013. Part 1: On Efficacy and Choice of Treatment

L. Puig, J.M. Carrascosa, G. Carretero,

Actas Dermo-Sifiliográficas

2013

62

Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry

E. Daudén, G. Carretero, R. Rivera,

Journal of the American Academy of Dermatology

2020

54

Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national <scp>BIOBADADERM</scp> registry

Carolina Medina, G. Carretero, Carlos Ferrándiz,

Journal of the European Academy of Dermatology and Venereology

2014

53

Guidelines for the Use of Acitretin in Psoriasis

G. Carretero, M. Ribera, I. Belinchón,

Actas Dermo-Sifiliográficas

2013

50

Page 1